Retraction notice to "The Impact of Emerging Therapies and Declining Physician Reimbursement on Dupuytren Disease Treatment: A 21-Year Review" [J Hand Surg Am. 2026;51(3):312]

Scritto il 06/05/2026
da Evan H Richman

J Hand Surg Am. 2026 May;51(5):606. doi: 10.1016/j.jhsa.2026.04.001.

ABSTRACT

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of Dr Brent Graham, former Editor-in-Chief. Post-publication, the journal received a Letter to the Editor alleging major methodological issues with the paper. The authors were requested to provide comment on these concerns and they agreed that the study had been done incorrectly, thus leading to inaccurate conclusions affecting a substantial portion of the work. The Editor is satisfied that no attempt to deceive was made on the part of the authors. However, the extent of changes required to correct the record is too significant to be addressed in a corrigendum. Consequently, the Editor has determined that the findings of the article in its present form cannot be relied upon, and has decided to retract the article. The authors agree with the retraction.

PMID:42091257 | DOI:10.1016/j.jhsa.2026.04.001